【Highlights】2025 Medlab Middle East Successfully Closed
发布日期：
2025-02-07
浏览次数：
0

【Highlights】2025 Medlab Middle East Successfully Closed



The much anticipated 24th MEDLAB Middle East took place in Dubai from 3-6 February 2025. As the world's largest exhibition of medical laboratory instruments and equipment, the event attracted professionals from the laboratory and diagnostic industries from all over the world. It served as an important platform to showcase the latest products and state of the art technologies, and also functioned as a professional international trade platform for medical laboratory equipment and detection in the Middle East region. As a key player in the industry, Beijing Diagreat Biotechnology Co., Ltd. actively participated in this grand event and shone brightly at the exhibition.

DIAGREAT


Highlight of Core Products

Diagreat Biotechnology showcased a number of hot-selling products at this exhibition, attracting the attention of numerous visitors. Among them, the automated chemiluminescence solution for therapeutic drug monitoring received much attention. With its advanced technology and stable performance, this solution can provide accurate and efficient test results for clinical therapeutic drug monitoring. It helps doctors adjust treatment plans according to the individual conditions of patients, thus improving the treatment effect. At the same time, Diagreat Biotechnology's IVD raw materials also demonstrated their high - quality and wide applicability at the exhibition, receiving high praise from peers.


【Highlights】2025 Medlab Middle East Successfully Closed

【Highlights】2025 Medlab Middle East Successfully Closed


【Highlights】2025 Medlab Middle East Successfully Closed


Take advantage of a opportunity and move up

Advancement of Diagreat Biotechnology's International Influence

During the exhibition, Diagreat Biotechnology's booth attracted a large number of professional visitors and potential customers for visits and exchanges. The company's professional team enthusiastically introduced the features and advantages of the products to the visitors, answered their questions and conducted in-depth communication and negotiations with many customers. Through this exhibition, diagreat Biotechnology not only enhanced its brand awareness and influence in the international market, but also established preliminary cooperation intentions with several international companies, laying a solid foundation for the company's future international development. In addition, by communicating and learning from other companies in the industry, the Company gained an understanding of the latest industry trends and market demands, which provided important reference for the Company's product research and development and market expansion.
【Highlights】2025 Medlab Middle East Successfully Closed


This participation in the Dubai International Medical Laboratory Instruments and Equipment Exhibition in the Middle East is an important step for Diagreat Biotechnology to enter the international market. Through the exhibition, Diagreat Biotechnology demonstrated its strength and advantages, and also reaped valuable experience and achievements. In future development, Diagreat Biotechnology will continue to increase investment in technology research and development and innovation, continuously improve the quality and performance of its products to meet the needs of domestic and international markets. At the same time, the company will actively expand the international market, strengthen cooperation and exchanges with international enterprises, and strive to build the company into a biotechnology enterprise with international competitiveness. It is believed that in the near future, Diagreat Biotechnology will achieve more brilliant achievements on the international stage.


【Highlights】2025 Medlab Middle East Successfully Closed



Last：Tacrolimus TDM application to stop "one size fits all" treatmentNext：Diagreat invites you to attend 2025 MEDLAB MIDDLE EAST

Related Recommendations